XLO Stock Analysis: Buy, Sell, or Hold?
XLO - Xilio Therapeutics, Inc. Common Stock
$7.79
-0.13 (-1.64%)
▼
5d:
-9.42%
30d:
-5.4%
90d:
+1161.13%
HOLD
LOW Confidence
Analysis Updated: Apr 29, 2026 12:00 AM ET
Earnings: May 14, 2026
13d
Get Alerted When XLO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XLO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: XLO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.80
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$7.33
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XLO is currently trading at $7.79, which is considered oversold relative to its 30-day fair value range of $8.17 to $8.62. The stock's valuation (Forward PE: 21.6) is in line with its historical norms (23.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, XLO is in a strong uptrend. Immediate support is located at $7.55, while resistance sits at $8.77.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+156.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XLO is in a strong uptrend. Immediate support is located at $7.55, while resistance sits at $8.77.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+156.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.17 -
$8.62
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 156.7% below Wall St target ($20.00)
- CAUTION: Recommendation downgraded due to -9.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$8.17 -
$8.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$7.55
Resistance Level
$8.77
Current Trend
Strong Uptrend
Technical data as of
Apr 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.64
Wall Street Target
$20.00
(+156.7%)
Revenue Growth (YoY)
693.9%
Profit Margin
-80.0%
Valuation Discount vs History
-2.6% cheaper
PE vs Historical
21.6 vs 23.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.6%
(market-implied from PE analysis)
1-Year Target
$7.59
(-3%)
2-Year Target
$7.39
(-5%)
3-Year Target
$7.20
(-8%)
3-Yr Target (if PE normalizes)
(PE: 22→23)
$7.78
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.6 to 23.4
Stabilization Target:
$8.42
(+8.1%)
PE Expansion Potential:
+8.1%
Share & Embed Analysis
Last updated: April 29, 2026 8:10 PM ET
Data refreshes hourly during market hours. Next update: 9:10 PM
Data refreshes hourly during market hours. Next update: 9:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XLO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 48 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 47 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$107 | 64 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |